Inhibition of tryptophan hydroxylase activity and decreased 5-HT1A receptor binding in a mouse model of Huntington's disease.
about
Mood disorders in Huntington's disease: from behavior to cellular and molecular mechanismsMolecular Imaging Markers to Track Huntington’s Disease PathologySexually dimorphic serotonergic dysfunction in a mouse model of Huntington's disease and depression.Treatment of depressive-like behaviour in Huntington's disease mice by chronic sertraline and exercise.The use of the R6 transgenic mouse models of Huntington's disease in attempts to develop novel therapeutic strategies.Transcriptional signatures in Huntington's disease.Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington's disease.A Tale of Two Maladies? Pathogenesis of Depression with and without the Huntington's Disease Gene Mutation.Results of the citalopram to enhance cognition in Huntington disease trial.Tryptophan hydroxylase: a target for neuroendocrine disruption.Zebrafish tyrosine hydroxylase 2 gene encodes tryptophan hydroxylase.Nuclear-targeting of mutant huntingtin fragments produces Huntington's disease-like phenotypes in transgenic mice.Altered serotonin receptor expression is associated with depression-related behavior in the R6/1 transgenic mouse model of Huntington's disease.Blood 5-hydroxytryptamine, 5-hydroxyindoleacetic acid and melatonin levels in patients with either Huntington's disease or chronic brain injury.Disease-modifying effects of ganglioside GM1 in Huntington's disease models.Expression of tryptophan hydroxylase in developing mouse taste papillae.
P2860
Q21131050-59DF5CEE-F5C9-4E28-A508-2FBFCB8538FDQ29248766-74E855D6-B964-46C8-B62B-43EA0F253603Q33961770-F40F304B-96AE-42AD-A283-509F65CBC165Q36024880-544BF06E-5A4D-444F-AF25-0543ED2D3FA4Q36358871-F40ADD61-5295-4C1E-8295-9B3B32A67B76Q36752799-1428FBA0-3B6E-415A-991B-7BF723AE8C27Q36931971-DE775260-8ABB-4DED-A891-732933D75378Q36993596-B0A3B2E7-D4A7-4881-8175-802E8A876682Q37649788-5453AC69-FA86-4A54-A760-444F7E781BBDQ37905812-D9A8F019-BE51-44CC-886B-3EA5F10933B6Q41942882-A121BBCE-0462-41BE-9CD9-3B1D5BA1A3B8Q44931209-3E7B8B6F-7CFF-45E9-BF3B-B163600DFD09Q45291543-C6495C2B-9A57-499C-A112-0246087A38F6Q45300518-6BF64CB1-5014-4B77-8962-24D70D347D32Q47154575-C2F96102-3C12-4573-983A-3F45B41A3D09Q52006435-A699328E-C085-4BC6-847A-EBD5677E4B2D
P2860
Inhibition of tryptophan hydroxylase activity and decreased 5-HT1A receptor binding in a mouse model of Huntington's disease.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Inhibition of tryptophan hydro ...... model of Huntington's disease.
@ast
Inhibition of tryptophan hydro ...... model of Huntington's disease.
@en
Inhibition of tryptophan hydro ...... model of Huntington's disease.
@nl
type
label
Inhibition of tryptophan hydro ...... model of Huntington's disease.
@ast
Inhibition of tryptophan hydro ...... model of Huntington's disease.
@en
Inhibition of tryptophan hydro ...... model of Huntington's disease.
@nl
prefLabel
Inhibition of tryptophan hydro ...... model of Huntington's disease.
@ast
Inhibition of tryptophan hydro ...... model of Huntington's disease.
@en
Inhibition of tryptophan hydro ...... model of Huntington's disease.
@nl
P2093
P2860
P1476
Inhibition of tryptophan hydro ...... model of Huntington's disease.
@en
P2093
Daniel J Robertson
George C-T Jiang
George J Yohrling IV
Jang-Ho J Cha
Kent E Vrana
Molly M DeJohn
P2860
P304
P356
10.1046/J.1471-4159.2002.01084.X
P407
P577
2002-09-01T00:00:00Z